Kyle Gano - Chief Business Development Off, Neurocrine Biosciences Inc

As of February 9, 2022


What is Kyle Gano's Net Worth?

The current estimated net worth of Neurocrine Biosciences Inc's Chief Business Development Off, Kyle Gano, is estimated to be about $30.58M . Kyle Gano owns about 111,173 units of Neurocrine Biosciences Inc common stock. In the last 9 years at Neurocrine Biosciences Inc, Kyle Gano has sold an estimated value of $22.02M worth.

What is Kyle Gano's Past Insider Trading?

Kyle Gano's largest purchase order was 28,266 units , worth over $244.78K on January 7, 2022. Kyle Gano's largest sale order was 28,266 units , worth over $3.25M on August 3, 2018. In total, Kyle Gano has made about 40 transactions over 9 years of their time at Neurocrine Biosciences Inc. Kyle Gano usually trades in February, with the busiest year in 2017. The most recent transaction was a sale order of 6,880 units , worth over $554.63K on February 9, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Kyle Gano's Salary in 2018?

As Chief Business Development Off of Neurocrine Biosciences Inc, Kyle Gano has a total base salary of $403,100 . Kyle Gano received compensation valued at about $4,568,241 in 2018 after becoming Chief Business Development Off. The vast majority of their compensation came in the form of a bonus of $191,473 , option awards of $1,309,024 , stock awards of $2,656,575 , and other compensation of $8,069 .

What is Kyle Gano's' Mailing Address?

  • Mailing address is Neurocrine Biosciences, Inc. 12780 el Camino Real San Diego CA 92130 CA

Neurocrine Biosciences Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Stock Awards
Other Compensation
Total
Kevin C. Gorman, Ph.D. 2018 $675,000 $425,250 $4,486,852 $2,998,832 $47,045 $8,632,979
Kevin C. Gorman, Ph.D. 2019 $725,000 $667,000 $6,000,525 $2,000,071 $58,230 $9,450,826
Kevin C. Gorman, Ph.D. 2020 $775,000 $542,500 $7,124,633 $5,375,188 $63,311 $13,880,632
Matthew C. Abernethy 2018 $420,000 $199,500 - $1,996,506 $69,741 $2,685,747
Matthew C. Abernethy 2019 $495,600 $284,970 $3,750,345 $1,250,035 $42,170 $5,823,120
Matthew C. Abernethy 2020 $545,200 $190,820 $2,999,869 $2,500,266 $45,021 $6,281,176
Eric Benevich 2018 $432,600 $205,485 $1,496,335 $1,499,417 $38,768 $3,672,605
Eric Benevich 2019 $467,200 $280,320 $3,750,345 $1,250,035 $45,547 $5,793,447
Eric Benevich 2020 $499,900 $199,960 $2,999,869 $3,000,257 $48,974 $6,748,960
Kyle W. Gano, Ph.D. 2018 $403,100 $191,473 $1,309,024 $2,656,575 $8,069 $4,568,241
Kyle W. Gano, Ph.D. 2019 $443,400 $266,040 $3,000,285 $1,000,076 $16,171 $4,725,972
Kyle W. Gano, Ph.D. 2020 $487,700 $207,273 $3,749,799 $2,750,210 $16,751 $7,211,733
Eiry W. Roberts, M.D. 2018 $490,700 $220,800 $2,863,700 $4,053,869 $671,554 $8,300,623
Eiry W. Roberts, M.D. 2019 $538,200 $309,465 $3,000,285 $1,000,076 $51,889 $4,899,915
Eiry W. Roberts, M.D. 2020 $575,900 $215,963 $2,624,855 $2,375,242 $56,073 $5,848,033
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/914475/000119312521111693/d87247ddef14a.htm

What are Neurocrine Biosciences Inc's Past Insider Trades?

Neurocrine Biosciences Inc's most recent insider trade came on May 11, 2022 by Richard Pops who sold 15,000 units worth $1.14M . In the last 19 years, insiders at Neurocrine Biosciences Inc have sold an estimated value of $350.93M and bought an estimated value of $59.47M worth of shares. Insider trading is most common in May, with the busiest year in 2017. The most active traders at the company are Dimitri Grigoriadis, Chief Research Officer,  Gary Lyons, Director,  and Haig Bozigian, Chief Development Officer .

NEUROCRINE BIOSCIENCES INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1